Logicbio therapeutics, inc. (LOGC)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Dec'17
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

43,153

33,107

38,680

25,456

27,870

80,906

12,877

24,575

Short-term investments

-

17,540

24,481

38,200

44,666

-

-

-

Prepaid expenses and other current assets

3,038

2,045

1,622

1,990

1,763

1,268

1,726

1,118

Restricted cash

146

146

146

146

-

-

-

-

Total current assets

46,337

52,838

64,929

65,792

74,299

82,174

14,603

25,693

Property and equipment, net

1,591

1,696

1,489

1,271

880

590

487

232

Restricted cash

622

622

0

-

146

146

-

-

Operating lease right-of-use asset

199

504

669

967

1,259

-

-

-

Other assets

-

-

-

-

57

-

1,906

249

TOTAL ASSETS

48,749

55,660

67,087

68,030

76,641

82,910

16,996

26,174

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable

2,181

624

1,954

1,657

1,413

1,168

983

1,112

Accrued expenses and other current liabilities

1,934

2,939

2,176

2,962

2,354

1,517

1,566

599

Deferred revenue

1,065

-

-

-

-

-

-

-

Total current liabilities

5,180

3,563

4,130

4,619

3,767

2,685

2,549

1,711

Long-term debt, net of issuance costs and discount

9,862

9,810

9,759

-

-

-

-

-

Other liabilities

-

-

-

-

58

-

-

-

Total liabilities

15,042

13,373

13,889

-

3,825

2,685

2,549

1,711

COMMITMENTS AND CONTINGENCIES (Note 13)

-

-

-

-

-

-

0

-

Convertible preferred stock, value

-

-

-

-

-

-

-

33,062

STOCKHOLDERS’ EQUITY:
Common stock, par value of $0.0001 per share; 175,000,000 shares authorized; 23,216,661 and 23,036,943 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

3

3

3

3

3

3

1

1

Additional paid-in capital

110,529

109,640

109,081

108,362

107,749

107,473

1,566

1,035

Accumulated other comprehensive income

-

14

19

33

3

-9

-1

-14

Accumulated deficit

-76,825

-67,370

-55,905

-44,987

-34,939

-27,242

-20,181

-9,621

Total stockholders’ equity

33,707

42,287

53,198

63,411

72,816

80,225

-18,615

-8,599

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

48,749

55,660

67,087

68,030

76,641

82,910

16,996

26,174

Series A Convertible Preferred Stock [Member]
Convertible preferred stock, value

-

-

-

-

-

-

-

4,359

Series B Convertible Preferred Stock [Member]
Convertible preferred stock, value

-

-

-

-

-

-

-

28,703